Physician profile
Alexander S Loreck
NPI 1073045530
$1,638.25
in general payments reported to CMS, 2019-2025
16 companies · $438 in 2025
The $438 reported for 2025 was more than what 89% of Hospice and Palliative Medicine (Internal Medicine) providers received nationally (typical 2025 total: $77.77).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $26.78 · 2021: $584 · 2022: $377 · 2024: $214 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $334.24 | 2021-2024 | Xarelto |
| Alexion Pharmaceuticals, INC. | $229.97 | 2021-2025 | Ultomiris |
| Abbvie INC. | $195.82 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $169.05 | 2020-2022 | |
| Pfizer INC. | $152.99 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $136.93 | 2024-2025 | Xifaxan |
| Gilead Sciences, INC. | $106.40 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $64.85 | 2022-2024 | |
| Janssen Biotech, INC. | $54.69 | 2025 | Talvey, Tecvayli |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.39 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $44.53 | 2021 | |
| Mallinckrodt Hospital Products INC. | $29.23 | 2025 | Terlivaz |
| Novo Nordisk INC | $22.10 | 2024 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.96 | 2025 | Lifevest |
| Merck Sharp & Dohme LLC | $17.07 | 2025 | Zerbaxa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evoke Pharma, INC. | $15.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Loreck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.